Maarten de Wit - Concepedia

Author

Maarten de Wit

Also Known As

D. A. van der Windt, Dorcas Beaton, EULAR PsAID Taskforce, George Padberg, J Myburgh, John Richard Kirwan, M De Wit, M P T de Wit, M de Wit, M. De Wit

299

Publications

27.8K

Citations

H-Index

101

Concepts

All Affiliations

Sorbonne Université Medical University of Vienna Amsterdam UMC Location Vrije Universiteit Amsterdam Assistance Publique – Hôpitaux de Paris Diakonhjemmet Hospital

About

Maarten de Wit is an author at Sorbonne Université specializing in medicine, outcomes research, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	2K
2	Nursing	6	6	1.3K
3	Engineering	3	3	55
4	Education	1	1	262
5	Health Sciences	1	1	26

Maarten de Wit

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Annals of the Rheumatic Diseases	2020	2.6K
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Annals of the Rheumatic Diseases	2013	1.8K
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials David T. Felson, Josef S Smolen, George A. Wells, Arthritis & Rheumatism	2011	1K
Shared decision making: really putting patients at the centre of healthcare Anne M. Stiggelbout, Trudy van der Weijden, Maarten de Wit, BMJ Family MedicineBehavioral Decision MakingClinical Decision-makingDecision ScienceIndividual Decision Making	2012	960
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Annals of the Rheumatic Diseases	2020	917
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials David T. Felson, Josef S Smolen, George A. Wells, Annals of the Rheumatic Diseases	2011	754
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force Josef S Smolen, Monika Schöls, Jürgen Braun, Annals of the Rheumatic Diseases	2017	662
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative Laure Gossec, Maarten de Wit, Uta Kiltz, Annals of the Rheumatic Diseases	2014	402
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis H.W. van Steenbergen, Daniel Aletaha, Liesbeth J J Beaart-van de Voorde, Annals of the Rheumatic Diseases	2016	299
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations Désirée van der Heijde, Daniel Aletaha, Loreto Carmona, Annals of the Rheumatic Diseases Eular Standing CommitteesEvidence-based MedicineSurgeryRheumatoid DisorderChronic Musculoskeletal Condition	2014	289

Page 1